Know Cancer

or
forgot password

Monitoring of Patients Treated With Particle Therapy Using Positron-Emission-Tomography (PET): The MIRANDA Study.


N/A
18 Years
N/A
Open (Enrolling)
Both
Particle Therapy

Thank you

Trial Information

Monitoring of Patients Treated With Particle Therapy Using Positron-Emission-Tomography (PET): The MIRANDA Study.

Inclusion Criteria


Inclusion Criteria

- The patient is treated at the Heidelberger Ionenstrahl Therapiezentrum (HIT) with
protons or carbon ions.

- During the radiotherapeutic treatment patient positioning is verified using validated
radiological imaging such as cone beam CT, X-ray or conventional CT
(Reference-Imaging as described above).

- The patient is at least 18 years of age and is able to give informed consent.

- The patient has been informed about the aims and the content of the study.

Exclusion Criteria

- No informed consent to take part in the study.

- Medical reasons that impair the patients from being in the supine position for the
data acquisition time, e.g. pain.

- Non-compliance of the patient.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

Stephanie E Combs, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital of Heidelberg

Authority:

Germany: Ethics Commission

Study ID:

MIRANDA

NCT ID:

NCT01528670

Start Date:

December 2011

Completion Date:

Related Keywords:

  • Particle Therapy

Name

Location